Back to Authors

Dall’Era, Marc

https://orcid.org/0000-0002-2301-2683

A5082241725 | I4390039352

Mayo Clinic

UC Davis Comprehensive Cancer Center

Citations 2

NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023

Journal of the National Comprehensive Cancer Network | March 10, 2023 | Volume: 21 | Issue: 3 | Pages: 236-246

10.6004/jnccn.2023.0014 | PMID 36898362

The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for individuals with a prostate who opt to participate in an early detection program after receiving the appropriate counseling on the pros and cons. These NCCN Guidelines Insights provide a summary of recent updates to the NCCN Guidelines with regard to the testing protocol, use of multiparametric MRI, and management of negative biopsy results to optimize the detection of clinically significant prostate cancer and minimize the detection of indolent disease.
Patients with Muscle-Invasive Bladder Cancer with Nonluminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant Chemotherapy

Journal of Urology | October 13, 2021 | Volume: 207 | Issue: 3 | Pages: 541-550

10.1097/ju.0000000000002261 | PMID 34643090